Changeflow GovPing Healthcare & Life Sciences Grifols Bio Supplies Trademark Publication
Routine Notice Added Final

Grifols Bio Supplies Trademark Publication

Favicon for changeflow.com USPTO Trademarks - Medical Services (Class 044)
Published
Detected
Email

Summary

The USPTO has published the trademark application "GRIFOLS BIO SUPPLIES" (TM79438455) for opposition. The application covers distributorship services for human-derived biological materials used in pharmaceutical, diagnostic, and research purposes. The publication date is March 20, 2026.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application "GRIFOLS BIO SUPPLIES" (Application No. TM79438455) for opposition. This publication signifies that the application has passed initial examination and is now open for third parties to oppose its registration. The application covers distributorship services for human-derived biological materials intended for use in the manufacture of pharmaceutical and diagnostic materials, as well as in life science research and the production of chemical reagents.

This publication is a procedural step in the trademark registration process and does not impose new compliance obligations on regulated entities. However, companies operating in the pharmaceutical, diagnostic, or life sciences sectors that may be affected by this trademark should monitor the opposition period. The filing date for this application was October 29, 2025, and the publication date is March 20, 2026. No compliance actions are required from external parties at this stage.

Archived snapshot

Mar 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

GRIFOLS BIO SUPPLIES

Published for Opposition TM79438455 Kind: published Mar 20, 2026

Abstract

Distributorship services featuring human-derived biological materials for use in the manufacture of pharmaceutical and diagnostic materials, and in life science research, and in the production of chemical reagents and control materials for pharmaceutical, diagnostic, and scientific research purposes; Provision of information about human-derived biological materials used in pharmaceutical and diagnostic manufacturing and life science research

Filing Date

2025-10-29

View original document →

Get daily alerts for USPTO Trademarks - Medical Services (Class 044)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 20th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM79438455

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceutical Manufacturing Life Sciences

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Services (Class 044) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!